¼¼°èÀÇ ¿ù°æÀüÁõÈıº ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ½ÃÀå
Premenstrual Syndrome and Menstrual Health Supplements
»óǰÄÚµå : 1792828
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 463 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿ù°æÀüÁõÈıº ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 246¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 200¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ù°æÀüÁõÈıº ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 3.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 246¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º¹ÇÕ ¿µ¾ç º¸ÃæÁ¦´Â CAGR 2.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 152¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ÜÀÏ ¿µ¾ç º¸ÃæÁ¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 54¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ù°æÀüÁõÈıº ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ½ÃÀåÀº 2024³â¿¡´Â 54¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 49¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.5%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.5%¿Í 2.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿ù°æÀüÁõÈıº ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°Ç°­º¸Á¶½ÄǰÀÇ Çõ½ÅÀº ¿©¼ºÀÇ ¿ù°æ °Ç°­ °ü¸®¸¦ ¾î¶»°Ô À籸¼ºÇϰí Àִ°¡?

¿ù°æÀüÁõÈıº(PMS) ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ½ÃÀåÀº È£¸£¸ó ±ÕÇü, ¿°Áõ Á¶Àý, Á¤¼­Àû ¾È³çÀ» ¸ñÇ¥·Î Çϴ Ư¼ö ¿µ¾ç º¸ÃæÁ¦ÀÇ µîÀåÀ¸·Î ÀÎÇØ Å« º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù¿¡´Â ü½ºÆ®º£¸® ÃßÃâ¹°(ºñÅØ½º ¾Æ±×´©½º Ä«½ºÅõ½º), ¸¶±×³×½·, ºñŸ¹Î B6, Ä®½·, ´Þ¸ÂÀÌ²É ¿ÀÀÏ, ¿À¸Þ°¡ 3 Áö¹æ»ê µî ±âºÐ ÀúÇÏ, °æ·Ã, º¹ºÎ ÆØ¸¸°¨, ÇÇ·Î µîÀÇ Áõ»óÀ» ¿ÏÈ­½ÃŰ´Â °ÍÀ¸·Î ¾Ë·ÁÁø ÀÓ»óÀûÀ¸·Î ¿¬±¸µÈ ¼ººÐÀ» Áß½ÉÀ¸·Î ¸¸µé¾îÁö´Â °æ¿ì°¡ ¸¹¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »ý¸®È°¼º È­ÇÕ¹°Àº ½Å°æÀü´Þ¹°Áú Á¶Àý, ÇÁ·Î½ºÅ¸±Û¶õµò Á¶Àý, ³»ºÐºñ°è ±ÕÇüÀ» Áö¿øÇÏ¿© ´Ü¼øÈ÷ Áõ»óÀ» ¼û±â´Â °ÍÀÌ ¾Æ´Ï¶ó PMSÀÇ ±Ùº»ÀûÀÎ ¸ÞÄ¿´ÏÁò¿¡ Á÷Á¢ÀûÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù.

ÃÖ±Ù ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀûÀÀÁ¦(¾Æ½´¿Í°£´Ù, ·Îµð¿Ã¶ó ·ÎÁ¦¾Æ µî), ½Ä¹°¼º ¿¡½ºÆ®·Î°Õ(Äá À̼ÒÇÃ¶óº» µî), Ç׿°Áõ Çãºê(°­È², »ý°­ µî)¸¦ Á¶ÇÕÇÑ ½Ã³ÊÁö È¿°úÀÇ ºí·»µùÀ» ÅëÇØ »ý¸® ÁÖ±âÀÇ ´Ù¾çÇÑ ´Ü°è¿¡ ¸Â´Â ÃÑüÀûÀÎ Á¾ÇÕÀûÀÎ º¸ÃæÁ¦ ¼Ö·ç¼ÇÀ» ¸¸µé¾î ³»°í ÀÖ½À´Ï´Ù. ŸÀÓ ¸±¸®½º ĸ½¶, ¼³ÇÏ ½ºÇÁ·¹ÀÌ, ±â´É¼º ±¸¹Ì´Â »ýü ÀÌ¿ë·ü°ú »ç¿ëÀÚ ¼øÀÀµµ¸¦ Çâ»ó½ÃÄÑ ÀϹÝÀûÀÎ Àü´Þ ÇüÅ·ΠÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ±â¹Ý º¸ÃæÁ¦ °³ÀÎÈ­ Ç÷§ÆûÀÌ µîÀåÇÏ¿© È£¸£¸ó ÇÁ·ÎÆÄÀϸµ, ¶óÀÌÇÁ½ºÅ¸ÀÏ, ½Ä½À°ü µîÀ» ±â¹ÝÀ¸·Î ¾Ë°í¸®ÁòÀÌ »ý¼ºÇÑ Ãßõ Á¦Ç°À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ÀÎÇØ º¸ÃæÁ¦´Â ´Ü¼øÈ÷ Áõ»óÀ» °ü¸®ÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó ¿©¼º »ý½Ä °Ç°­À̶ó´Â Å« °üÁ¡¿¡¼­ Àå±âÀûÀÎ °Ç°­À» ÃÖÀûÈ­ÇÏ´Â °ÍÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

°Ç°­±â´É½ÄǰÀº ±âÁ¸ÀÇ ½ÃÁß¿¡¼­ ÆÇ¸ÅµÇ´Â ¿ÏÈ­Á¦Ç°À» ³Ñ¾î ¾îµð±îÁö ÁøÃâÇÒ ¼ö ÀÖÀ»±î?

PMS¿Í ¿ù°æ °Ç°­À» À§ÇÑ º¸ÃæÁ¦´Â ¾à±¹À̳ª ¼Ò¸Å üÀÎÀÇ Æ²À» ³Ñ¾î ´Ù¾çÇÑ »õ·Î¿î ¿µ¿ª¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ºÐ¾ß¿¡¼­´Â »ý¸® ÃßÀû ¾ÛÀ» Á¦°øÇÏ´Â ÆèÅ×Å© Ç÷§ÆûÀÌ º¸ÃæÁ¦ Á¤±â ±¸¸Å¿Í °³ÀÎÈ­µÈ Áֱ⿡ ´ëÇÑ ÀλçÀÌÆ®¸¦ ÅëÇÕÇÑ »ý¸® ÃßÀû ¾ÛÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. DTC(Direct-to-Consumer) ºê·£µå´Â ¿ù°æ °Ç°­ ŰƮ¿¡ º¸ÃæÁ¦, ÇãºêÂ÷, ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ °áÇÕÇÑ ¿ù°æ °Ç°­ ŰƮ¸¦ Á¤±â ±¸¸Å ±â¹Ý À£´Ï½º ¿¡ÄڽýºÅÛÀÇ ÀϺηΠÆÐŰ¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ Á¦Ç°µéÀº ÆíÀǼº, ÇÁ¶óÀ̹ö½Ã, Åõ¸í¼ºÀ» Ãß±¸ÇÏ´Â ¼ÒºñÀÚ, ƯÈ÷ õ¿¬ ´ëüǰ°ú ÷´Ü ±â¼úÀ» Ȱ¿ëÇÑ °Ç°­ ¼Ö·ç¼Ç¿¡ ¸Å·ÂÀ» ´À³¢´Â ÀþÀº ÃþÀ» Ÿ°ÙÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.

Á÷Àå°ú ´ëÇеµ À¯Åë °ÅÁ¡À¸·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ±â¾÷ À£´Ï½º ÇÁ·Î±×·¥°ú Çлý °Ç°­ ÀÌ´Ï¼ÅÆ¼ºê´Â ´õ ±¤¹üÀ§ÇÑ ¿ù°æ Æòµî Ä·ÆäÀÎÀÇ ÀÏȯÀ¸·Î º¸ÃæÁ¦¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ºÒÀÓ Å¬¸®´Ð°ú ºÎÀΰú ¼¾ÅÍ¿¡¼­´Â ºÒ±ÔÄ¢ÇÑ »ý¸®ÁÖ±â, ´Ù³¶¼º³­¼ÒÁõÈıº(PCOS), Ȳü±â ºÎÀüÀ» °æÇèÇϴ ȯÀÚ¸¦ À§ÇÑ ÅëÇÕÀû Ä¡·á °èȹ¿¡ º¸ÃæÁ¦¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ¹× Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ ºÐ¾ß¿¡¼­ ¿îµ¿¼±¼ö¿Í ÇÇÆ®´Ï½º¿¡ ¿­¼ºÀûÀÎ ¿©¼ºµéÀº °æ±â·ÂÀÇ ¾ÈÁ¤¼ºÀ» À¯ÁöÇϱâ À§ÇØ ÁÖ±â Á¶Àý º¸ÃæÁ¦¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â°ü, µðÁöÅÐ, ¶óÀÌÇÁ½ºÅ¸ÀÏ Áß½ÉÀÇ Ã¤³Î·ÎÀÇ È®ÀåÀº º¸ÃæÁ¦ÀÇ ÀÎÁöµµ¸¦ ³ôÀ̰í, ´õ ³ÐÀº ¿¹¹æ °Ç°­ÀÇ Æ²¿¡ º¸ÃæÁ¦¸¦ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù.

¼ÒºñÀÚÀÇ ÃëÇâ°ú °Ç°­ ÀνÄÀÇ º¯È­°¡ Á¦Çü°ú ºê·£µù¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

Çö´ë ¼ÒºñÀÚ, ƯÈ÷ ¹Ð·¹´Ï¾ó ¼¼´ë¿Í Z¼¼´ë´Â Ŭ¸° ¶óº§, ºñ°Ç, ºñ°Ç, ¾Ë·¹¸£°Õ ÇÁ¸®, À±¸®ÀûÀ¸·Î Á¶´ÞµÈ ¿ø·á¸¦ ¿ä±¸ÇÏ¸ç »ý¸® ¹× º¸ÃæÁ¦ »ç¿ë¿¡ ´ëÇÑ ±â´ëÄ¡¸¦ ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù. º¸ÃæÁ¦ Á¦Á¶¾÷üµéÀº ÀÌ·¯ÇÑ ±âÈ£¿¡ ºÎÀÀÇϱâ À§ÇØ À¯ÀüÀÚ º¯ÇüÀÌ ¾ø´Â ½Ä¹°, ¹«¼³ÅÁ, ¹«ÇÃ¶ó½ºÆ½ Æ÷Àå, Á¦ 3ÀÇ ±â°ü¿¡ ÀÇÇÑ Å×½ºÆ® µîÀ» Á¡Á¡ ´õ °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÓ»óÀû °ËÁõ°ú µðÁöÅÐ ÃßÀû¼ºÀ» ¹ÙÅÁÀ¸·Î ÇÑ ¶óº§ Ç¥½ÃÀÇ Åõ¸í¼ºÀº ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Çʼö Á¶°ÇÀÌ µÇ°í ÀÖ½À´Ï´Ù. Àαâ ÀÖ´Â Æ÷Áö¼Å´× Àü·«Àº 'È£¸£¸ó ¾ø´Â ±¸Á¦', '±Ùº»ÀûÀÎ ¿øÀο¡ ´ëÇÑ Áö¿ø', '»çÀÌŬ ½ÌÅ©'¿¡ ÃÊÁ¡À» ¸ÂÃß°í, Ä¡·á¿¡¼­ ¹Ùµð ¸®ÅÍ·¯½Ã¿Í ÀÓÆÄ¿ö¸ÕÆ®·Î À̾߱⸦ ÀüȯÇϰí ÀÖ½À´Ï´Ù.

¼Ò¼È ¹Ìµð¾î¿Í ÀÎÇ÷ç¾ð¼­ ¸¶ÄÉÆÃÀº ÀÎÁöµµ¸¦ Çü¼ºÇϰí Á¦Ç° ¹ß°ßÀ» ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿ù°æ °úÇÐ, ½Åü ±àÁ¤¼º, ÀüÀÎÀû À£ºùÀ» °­Á¶ÇÏ´Â ±³À° Ä·ÆäÀÎÀº ¿ù°æÀÇ ¹®È­Àû ºñ¹°ÁúÈ­¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ¿ù°æ Áö¿ø ÀǽĿ¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Æ®·£½ºÁ¨´õ¿Í ºñÀ̼º¾ÖÀÚ, ºñÀ̼º¾ÖÀÚ ¿ù°æÀεéÀ» À§ÇÑ Á¾ÇÕÀûÀÎ ºê·£µùÀÇ µîÀåÀº ¿ù°æ °Ç°­º¸Á¶½ÄǰÀÇ ÀÌ¿ëÀÚ¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ¼¼°è ½ÃÀå¿¡ ħÅõÇϱâ À§ÇØ ´Ù±¹¾î Ç¥½Ã, ¹®È­Àû Á¶Á¤, Áö¿ªº° Á¦Ç° ó¹æÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °úÇÐÀû ½Å·Ú¼º, À±¸®Àû Á¦Á¶, Á¾ÇÕÀûÀÎ Ä¿¹Â´ÏÄÉÀ̼ÇÀÇ À¶ÇÕÀº ¿ù°æ °Ç°­º¸Á¶½ÄǰÀÇ Ã³¹æ, ÆÇ¸Å ¹× ¼ÒºñÀÇ ¹æ½ÄÀ» ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù.

¿ù°æ °Ç°­º¸Á¶Á¦ ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» À̲ô´Â ÈûÀº ¹«¾ùÀϱî?

¼¼°è PMS ¹× ¿ù°æ °Ç°­º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀº ¿©¼º °Ç°­ ¹®Á¦¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, »ý½Ä °Ç°­ Á¤º¸¿¡ ´ëÇÑ Á¢±Ù¼º Áõ°¡, ºñ¾à¹°Àû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. PMS´Â Àü ¼¼°èÀûÀ¸·Î ¿ù°æÇÏ´Â ¿©¼ºÀÇ 70% ÀÌ»ó¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡¸ç, ±× Áõ»óÀº °¡º­¿î ºÒÆíÇÔ¿¡¼­ ½É°¢ÇÑ ±âºÐ Àå¾Ö ¹× ÅëÁõ Àå¾Ö¿¡ À̸£±â±îÁö ´Ù¾çÇϱ⠶§¹®¿¡ ¿©¼ºµéÀº ±âÁ¸ÀÇ ÁøÅëÁ¦ ¹× È£¸£¸ó Ä¡·á ´ë½Å º¸´Ù ¾ÈÀüÇϰí ÀÚ¿¬ÀûÀÎ ´ë¾ÈÀ» Àû±ØÀûÀ¸·Î ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä´Â ƯÈ÷ µµ½Ã Áö¿ª°ú °Ç°­°ü¸®¿¡ Àû±ØÀûÀ̰í, ±³À°À» ¹Þ°í, µðÁöÅзΠ¿¬°áµÈ »ç¶÷µé »çÀÌ¿¡¼­ °­ÇÕ´Ï´Ù.

¿ù°æ À§»ý ±³À° ¹× ¿ù°æ À§»ý °ü¸®(MHM)¸¦ Áö¿øÇÏ´Â Á¤ºÎ ¹× ºñÁ¤ºÎ Â÷¿øÀÇ ³ë·ÂÀº °£Á¢ÀûÀ¸·Î ¿µ¾ç ºÒ±ÕÇü°ú È£¸£¸ó °Ç°­¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ¿Í º´ÇàÇÏ¿©, E-Commerce Ç÷§Æû°ú °Ç°­¿¡ ÃÊÁ¡À» ¸ÂÃá ¸¶ÄÏÇ÷¹À̽º´Â Æ´»õ½ÃÀå°ú ÇÁ¸®¹Ì¾ö º¸ÃæÁ¦ ºê·£µå¿¡ ´ëÇÑ ¼¼°è Á¢±ÙÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ¿ù°æ °Ç°­, Àå °Ç°­, ¸¶À½ °Ç°­, È£¸£¸ó Á¶È­ µî º¸´Ù ±¤¹üÀ§ÇÑ À£ºù Æ®·»µå¿ÍÀÇ ±³Â÷Á¡Àº º¸´Ù ±¤¹üÀ§ÇÑ ¼ÒºñÀÚ ´ÏÁ ÃæÁ·½Ã۱â À§ÇÑ ¹ü Ä«Å×°í¸®º° Á¦Ç° Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÆèÅ×Å©¿Í ¿©¼º Áß½ÉÀÇ °Ç°­ º¥Ã³¿¡ ´ëÇÑ ÅõÀÚ ÀÇ¿åÀº º¸ÃæÁ¦ ±â¾÷ÀÇ ¿¬±¸ °³¹ß ¹× È®Àå ´É·ÂÀ» ÃËÁøÇÏ°í ´õ ºü¸¥ Á¦Ç° °³¹ß ¹× ¼¼°è È®ÀåÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. °Ç°­±â´É½Äǰ ºê·£µå¿Í ÇコÄɾî Àü¹®°¡¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ÀÇ·á ¼ö¿ë¼º°ú ¼ÒºñÀÚ ½Å·Ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶óÀÌÇÁ½ºÅ¸ÀÏ À£ºù ½Ä´Ü¿¡ÀÇ ÅëÇÕ, °Ç°­º¸Á¶½Äǰ¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø Áõ°¡, ¿ù°æÀÇ ¹®È­Àû Á¤»óÈ­ Ãß¼¼¿¡ µû¶ó PMS ¹× ¿ù°æ °Ç°­º¸Á¶½Äǰ ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È ¼±Áø±¹°ú ½ÅÈï Áö¿ª ¸ðµÎ¿¡¼­ µÎ ÀÚ¸´¼ö ¼ºÀåÀ» Áö¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(º¹ÇÕ ¿µ¾ç º¸ÃæÁ¦, ´ÜÀÏ ¿µ¾ç º¸ÃæÁ¦), ÀûÀÀÁõ(°»³â±âÀå¾Ö ÀûÀÀÁõ, PMS ÀûÀÀÁõ), ÇüÅÂ(ĸ½¶/Á¤Á¦ ÇüÅÂ, ºÐ¸» ÇüÅÂ, ¼ÒÇÁÆ®Á© ÇüÅÂ, ±âŸ ÇüÅÂ), ÃÖÁ¾»ç¿ëÀÚ(¾à±¹/µå·°½ºÅä¾î ÃÖÁ¾»ç¿ëÀÚ, ¿Â¶óÀÎ À¯Åë ÃÖÁ¾»ç¿ëÀÚ, Á÷Á¢ À¯Åë ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Premenstrual Syndrome and Menstrual Health Supplements Market to Reach US$24.6 Billion by 2030

The global market for Premenstrual Syndrome and Menstrual Health Supplements estimated at US$20.0 Billion in the year 2024, is expected to reach US$24.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Combined Nutritional Supplements, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$15.2 Billion by the end of the analysis period. Growth in the Single Nutritional Supplements segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 6.5% CAGR

The Premenstrual Syndrome and Menstrual Health Supplements market in the U.S. is estimated at US$5.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Premenstrual Syndrome and Menstrual Health Supplements Market - Key Trends & Drivers Summarized

How Are Nutraceutical Innovations Reshaping Menstrual Health Management for Women?

The premenstrual syndrome (PMS) and menstrual health supplements market is undergoing a significant shift, propelled by the rise of specialized nutraceuticals targeting hormonal balance, inflammation control, and emotional well-being. Modern formulations are increasingly built around clinically studied ingredients such as chasteberry extract (Vitex agnus-castus), magnesium, vitamin B6, calcium, evening primrose oil, and omega-3 fatty acids-known to alleviate symptoms such as mood swings, cramps, bloating, and fatigue. These bioactive compounds support neurotransmitter regulation, prostaglandin modulation, and endocrine system balance, directly addressing underlying mechanisms of PMS rather than merely masking symptoms.

Recent innovations involve synergistic blends combining adaptogens (e.g., ashwagandha, Rhodiola rosea), phytoestrogens (e.g., soy isoflavones), and anti-inflammatory herbs (e.g., turmeric, ginger) to create holistic supplement solutions tailored for different phases of the menstrual cycle. Time-release capsules, sublingual sprays, and functional gummies are becoming popular delivery formats, enhancing bioavailability and user compliance. Additionally, AI-enabled supplement personalization platforms are emerging, offering algorithm-generated recommendations based on hormonal profiling, lifestyle, and diet. These advances are positioning supplements not just as symptom managers but as long-term health optimizers within the larger landscape of female reproductive wellness.

Where Are Supplements Gaining Ground Beyond Traditional Over-the-Counter Relief Products?

Supplements for PMS and menstrual health are gaining traction across a variety of new domains beyond pharmacies and retail chains. In the digital health space, femtech platforms offering menstrual tracking apps are integrating supplement subscriptions with personalized cycle insights. Direct-to-consumer (DTC) brands are packaging menstrual health kits that combine supplements, herbal teas, and probiotics as part of subscription-based wellness ecosystems. These offerings target consumers seeking convenience, privacy, and transparency-particularly younger demographics drawn to natural alternatives and tech-enabled health solutions.

Workplaces and universities are also emerging as distribution points, where corporate wellness programs and student health initiatives provide supplement access as part of broader menstrual equity campaigns. In parallel, fertility clinics and gynecology centers are incorporating supplements into integrative treatment plans for patients experiencing irregular cycles, polycystic ovarian syndrome (PCOS), and luteal phase defects. In sports and active lifestyles segments, athletes and fitness-focused women are turning to cycle-regulating supplements to maintain performance consistency. This expansion into institutional, digital, and lifestyle-driven channels is increasing supplement visibility and embedding it within a wider preventive health framework.

How Are Changing Consumer Preferences and Health Awareness Impacting Formulation and Branding?

Modern consumers-especially millennials and Gen Z-are redefining expectations around menstruation and supplement use by demanding clean-label, vegan, allergen-free, and ethically sourced ingredients. Supplement manufacturers are increasingly emphasizing non-GMO botanicals, zero added sugar, plastic-free packaging, and third-party testing to appeal to these preferences. Transparency in labeling, backed by clinical validation and digital traceability, is becoming a prerequisite for market success. Popular positioning strategies focus on "hormone-free relief," "root-cause support," and “cycle syncing,” shifting the narrative from disorder treatment to body literacy and empowerment.

Social media and influencer marketing are playing a critical role in shaping perceptions and driving product discovery. Educational campaigns emphasizing menstrual science, body positivity, and holistic wellness are contributing to a cultural destigmatization of menstruation-thereby fostering demand for monthly support rituals. Furthermore, the rise of inclusive branding that addresses transgender and non-binary menstruators is expanding the audience for menstrual health supplements. Multilingual labeling, cultural tailoring, and region-specific product formulations are being used to penetrate diverse global markets. This fusion of scientific credibility, ethical manufacturing, and inclusive communication is redefining the way menstrual health supplements are formulated, marketed, and consumed.

What Forces Are Driving the Global Growth of the Menstrual Health Supplements Market?

The growth in the global PMS and menstrual health supplements market is driven by rising awareness of women’s health issues, increased access to reproductive wellness information, and growing demand for non-pharmaceutical interventions. As the prevalence of PMS affects over 70% of menstruating individuals globally-with symptoms ranging from mild discomfort to severe mood and pain disorders-women are actively seeking safer, natural alternatives to conventional analgesics and hormonal treatments. This demand is particularly strong in urban areas and among educated, digitally connected populations who are proactive in health management.

Government and non-government initiatives supporting menstrual health education and menstrual hygiene management (MHM) are indirectly boosting awareness of nutritional gaps and hormonal health. In parallel, e-commerce platforms and health-focused marketplaces are enabling global access to niche and premium supplement brands. The intersection of menstrual health with broader wellness trends-such as gut health, mental wellness, and hormonal harmony-is driving cross-category product innovations that cater to a wider spectrum of consumer needs.

Investment interest in femtech and women-centric health ventures is fueling R&D and scaling capabilities for supplement companies, enabling faster product development and global expansion. Strategic partnerships between supplement brands and healthcare professionals are enhancing medical acceptance and consumer trust. With increasing integration into lifestyle wellness regimens, rising regulatory support for dietary supplements, and growing cultural normalization of menstruation, the PMS and menstrual health supplements market is expected to witness consistent, double-digit growth across both developed and emerging regions in the coming years.

SCOPE OF STUDY:

The report analyzes the Premenstrual Syndrome and Menstrual Health Supplements market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Combined Nutritional Supplements, Single Nutritional Supplements); Indication (Perimenopause Indication, PMS Indication); Form (Capsules / Tablets Form, Powder Form, Softgel Form, Other Forms); End-Use (Pharmacies / Drug Stores End-Use, Online Distribution Channel End-Use, Direct Distribution Channel End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â